Arkolith/Insider Trading/VTGN/Form 4

Adler Reid G.

Chief Legal OfficerVistagen Therapeutics, Inc. (VTGN) · full profile →Form 4 · filed Jul 1, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 30, 2025Grant(A)8K$1.70$13K24K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-25-018755) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML